Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01350440 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia
A Phase 2 study of Spinocerebellar Ataxia, sponsored by University of South Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT01350440: Completed Phase 2 study of Spinocerebellar Ataxia, sponsored by University of South Florida.
NCT01350440 is a Phase 2 study of Spinocerebellar Ataxia that has completed, run by University of South Florida. The registered enrollment target is 5 participants, below the 215-participant average among 3 other Spinocerebellar Ataxia trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01350440, a Phase 2 study of Spinocerebellar Ataxia, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a preliminary study to determine the safety and efficacy of intravenous immune globulin in treating Spinocerebellar Ataxia. The investigators aim to assess changes in clinical measures of disease severity before and after treatment.
Conditions Studied
Interventions
- BIOLOGICAL IVIG
Study Locations (1)
Florida
- University of South Florida - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2011-08 |
| Est. Completion | 2013-07 |
| Phase | Phase 2 |
What the finished NCT01350440 record still lists
NCT01350440 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 215-participant average among 3 other Spinocerebellar Ataxia trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Spinocerebellar Ataxia appearing as the primary indexed condition, and to 1 intervention - of which IVIG is the first listed.
NCT01350440 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT01350440 about?
NCT01350440 is a clinical study titled "Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia". This is a preliminary study to determine the safety and efficacy of intravenous immune globulin in treating Spinocerebellar Ataxia. The investigators aim to assess changes in clinical measures of disease severity before and after treatment.
What is the current status of trial NCT01350440?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2011-08. Estimated completion is 2013-07.
What conditions does trial NCT01350440 study?
This clinical trial studies the following conditions: Spinocerebellar Ataxia.
What interventions are being tested in trial NCT01350440?
The interventions under investigation include: IVIG (BIOLOGICAL).
Who is sponsoring clinical trial NCT01350440?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01350440 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinocerebellar Ataxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia